Skip to content

Apotheek L. Horsten

Active
Private limited companyfounded 2010active for 16 yearsVrijheid 98, 2320 Hoogstraten, BelgiumKBO/BCE: BE 0829.283.286
Summary

Apotheek L. Horsten has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €666,918 and a net result of €113,758. Equity has been growing by about 11% per year since 2018. Its solvency ranks better than 83% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 14-09-2010 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2024
Establishment unit
2.191.605.132 2320 Hoogstraten, since 01-10-2010
Financial year end
31 December
Peppol
Reachable since 21-10-2026

Board and ownership

Board
  • Horsten LiesDirector

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€399,907
▲ 4.8%
Turnover
≈ €1.5m
estimated
Profit
€113,758
▲ 29.6%
Equity
€666,918
▲ 17.4%
Total assets
€929,410
▼ 8.1%
Employees on 31-12-2025
5
=
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskFounded in 2010Figures for financial year 2025 (filed on 31-07-2026)Equity €666,918 (71.8% of total assets)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 68% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 97+16
equity 71.8% of total assets
Liquidity 44+9
short-term debt 24.6% · cash 2.4%
Profitability 84+4
return on assets 12.2%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.2% 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.3%▲ +0.1 percentage points vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025 08-2025: 0.7%▲ +0.3 percentage points vs 07-2025highest value 09-2025: 0.2%▼ -0.5 percentage points vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.3%▲ +0.1 percentage points vs 06-2026 08-2026: 0.1%▼ -0.2 percentage points vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value 11-2026: 0.1%● unchanged vs 10-2026lowest value
Credit of up to €60,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.54 (2.24 in 2024), above the usual 1.5. Short-term debt is 24.6% and cash 2.4% of total assets. 28.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 82% of them on solvency, 42% on liquidity, 78% on profitability and 70% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 2010
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Figures for financial year 2025 (filed on 31-07-2026)
NBB · annual accounts
lowers risk · Equity €666,918 (71.8% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
12 days late
2023
22 days early
2022
25 days early
2021
2 days early
2020
10 days late
2019
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 4 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 83% of companies in retail tradesector median 36.6% · 12,775 companies 71.8% View
  • Positive: 8 profitable years in a rowprofit 2025: €113,758 8 years View

Recent changes

  1. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as Apotheek L. Horsten: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €817,000 and €1m, founded between 2007 and 2013.

CompanyTotal assetsGross margin
Apotheek L. Horsten Hoogstraten€0.9m€0.4m
Pharmacie Walcarius Beloeil€1.0m€0.4m
Pharmacie de la Linière Perwez€0.9m€0.4m
KRUISPUNT APOTHEEK Antwerpen€1.0m€0.4m
APOTHEEK VAN DOREN Mechelen€0.8m€0.4m
Apotheek Mouton Evergem€1.0m€0.4m
APOTHEEK DONCKERWOLCKE Veurne€1.0m€0.4m
Full comparison

Key facts about Apotheek L. Horsten

What is the company number of Apotheek L. Horsten?
The company number of Apotheek L. Horsten is 0829.283.286. The VAT number is the same number with BE in front: BE 0829.283.286.
Where is Apotheek L. Horsten based?
The registered office is at Vrijheid 98, 2320 Hoogstraten.Company details
What does Apotheek L. Horsten do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek L. Horsten?
The legal form of Apotheek L. Horsten is Private limited company (BV).
When was Apotheek L. Horsten founded?
Apotheek L. Horsten was founded on 14-09-2010.
Is Apotheek L. Horsten still active?
Yes, Apotheek L. Horsten is an active enterprise in the KBO register.
How many employees does Apotheek L. Horsten have?
Apotheek L. Horsten had an average of 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Apotheek L. Horsten fall under?
In its 2024 annual accounts, Apotheek L. Horsten states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of Apotheek L. Horsten?
The turnover in financial year 2025 is ≈ €1.5m. This figure is estimated from the gross margin of €399,907 and 47 comparable companies (NACE 477). It probably lies between €1.1m and €2.4m.
Is Apotheek L. Horsten profitable?
In financial year 2025, Apotheek L. Horsten made a profit of €113,758.
Where can I find the annual accounts of Apotheek L. Horsten?
Apotheek L. Horsten filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek L. Horsten due?
Apotheek L. Horsten must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.